Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
AstraZeneca
US Department of Justice
Queensland Health
Merck

Generated: August 20, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: TERIPARATIDE RECOMBINANT HUMAN

  Try a free trial


See Plans and Pricing

« Back to Dashboard

TERIPARATIDE RECOMBINANT HUMAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly FORTEO teriparatide recombinant human INJECTABLE;SUBCUTANEOUS 021318 NDA Eli Lilly and Company 0002-8400-01 1 SYRINGE in 1 CARTON (0002-8400-01) > 2.4 mL in 1 SYRINGE
Lilly FORTEO teriparatide recombinant human INJECTABLE;SUBCUTANEOUS 021318 NDA Eli Lilly and Company 0002-8400-99 1 SYRINGE in 1 CARTON (0002-8400-99) > 2.4 mL in 1 SYRINGE
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Chinese Patent Office
Argus Health
McKinsey
Boehringer Ingelheim